This chapter is a brief introduction to pathogenic microorganisms and also discusses virulence factors. An understanding of virulence factors is important, as they represent potential targets for the detection of microbial pathogens. Sources and routes of infection are also briefly discussed with reference to specific examples. There are a number of ways in which infection could be acquired, including via contaminated food and water; hospital acquired infection; “naturally acquired” infection; and intentional infection, for example, through the use of biological warfare agents. The focus of the review is predominantly on human pathogens. However, there are a range of other microbial pathogens of particular importance in other areas; for example, animal and plant pathogens, which will not be discussed. Finally, a brief overview of the detection of pathogenic bacteria is presented.


Virulence Factor Pathogenic Microorganism Foodborne Pathogen Bordetella Pertussis Yersinia Pestis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Arora K, Chand S, Malhotra BD (2006) Anal Chim Acta 568:259–74CrossRefGoogle Scholar
  2. Bliska JB, Galan JE, Falkow S (1993) Signal transduction in the mammalian cell during bacterial attachment and entry. Cell 73:903–920CrossRefGoogle Scholar
  3. Brubaker RR (1985) Mechanisms of bacterial virulence. Ann Rev Microbiol 39:21–50CrossRefGoogle Scholar
  4. Brunham RC, Pummer FA, Stephens RS (1993) Bacterial antigenic variation host immune response and pathogen-host coevolution. Infect Immun 61:2273–2276Google Scholar
  5. Cassadevall A, Pirofski L (1999) Host-pathogen interactions: redefining the basic concepts of virulence and pathogenicity. Infect Immun 67(8):3703–3713Google Scholar
  6. Cassadevall A, Pirofski L (2001) Host-pathogen interaction: the attributes of virulence. J Infect Dis 184:337–344CrossRefGoogle Scholar
  7. Christopher GW, Cieslak TJ, Pavlin JA, Eitzen EM (1997) Biological warfare: a historical perspective. JAMA 278(5):412–417CrossRefGoogle Scholar
  8. Coella R et al (1993) The cost of infection in surgical patients: a case study. J Hosp Infect 25:239–250CrossRefGoogle Scholar
  9. Daffe M, Etienne G (1999) The capsule of Mycobacterium tuberculosis and its implications for pathogenicity. Tubercul Lung Dis 79:153–169CrossRefGoogle Scholar
  10. Dietsch KW, Moxon ER, Wellems TE (1997) Shared themes of antigenic variation and virulence in bacteria, protozoal and fungal infections. Microbiol Mol Biol Rev 61:281–293Google Scholar
  11. Eitzen EM (1997) Use of biological weapons. In: Sidell SR, Takafugi ET, Franz DR (Eds) Medical aspects of chemical and biological warfare. TMM Publications, Washington, DC, pp 437–450Google Scholar
  12. Falk IS (1928) A theory of microbiologic virulence. In: Jordan EO, Falk IS (Eds) The newer knowledge of bacteriology and immunology. University of Chicago Press, Chicago IL, pp 565–575Google Scholar
  13. Falkow S (1997) What is a pathogen? ASM News 63:136–169Google Scholar
  14. Falzano L, Fiorenti C, Donelli G, Michel E, Kocks C, Cossart P, Cabanie L, Oswald E, Boquet P (1993) Induction of phagocytic behaviour in human epithelial cells by Escherichia coli cytotoxic necrotising factor type I. Mol Microbiol 9:1247–1254CrossRefGoogle Scholar
  15. Finlay BB, Falkow S (1997) Common themes in microbial pathogenicity revisited. Microbiol Mol Biol Rev 61(2):136–169Google Scholar
  16. Geddes AM, Ellis CJ (1985) Infection in immunocompromised patients. Q J Med 55(216):5–14Google Scholar
  17. Gross R (1993) Signal transduction and virulence regulation in human and animal pathogens. FEMS Microbiol Rev 10:301–326Google Scholar
  18. Hambleton P, Turnbull PC (1990) Anthrax vaccine development: a continuing story. Adv Biotechnol Processes 13:105–122Google Scholar
  19. Hava DL, Camilli A (2002) Large scale identification of serotype 4 Streptococcus pneumoniae virulence factors. Mol Microbiol 45(5):1389–1405Google Scholar
  20. Hawley RJ, Eitzen EM (2001) Biological weapons—a primer for microbiologists. Ann Rev Microbiol 55:235–253CrossRefGoogle Scholar
  21. Helrich K (Ed) (1990) Official methods of analysis of the association of official analytical chemists, 15th Edition. Association of Analytical Chemists Inc, Gaithersburg, MD, pp 449–450Google Scholar
  22. Henchal EA et al. (2001) Current laboratory methods for biological threat agent identification. Clin Lab Med 21(3):661-+Google Scholar
  23. Henderson B, Poole S, Wilson M (1996) Bacterial modulins: a novel class of virulence factors which cause host tissue pathology by inducing cytokine synthesis. Microbiol Rev 60:316–341Google Scholar
  24. Hobson NS, Tothill I, Turner AP (1996) Microbial detection. Biosens Bioelectron 11(5):455–477CrossRefGoogle Scholar
  25. Hultgren SJ, Abraham SN, Capron M, Falk P, St Geme JW, Normark S (1993) Pilus and nonpilus bacterial adhesins assembly, function, and recognition. Cell 73:887–901CrossRefGoogle Scholar
  26. Ivnitski D, Abdel-Hamid I, Atanasov P, Wilkins E (1999) Biosensors for the detection of pathogenic bacteria. Biosens Bioelectron 14:599–624CrossRefGoogle Scholar
  27. Koch S, Wolf H, Danapel C, Feller KA (2000) Optical flow-cell multichannel immunosensor for the detection of biological warfare agents. Biosens Bioelectron 14:779–784CrossRefGoogle Scholar
  28. Kenny B, Devinney R, Stein M (1997) Enteropathogenic E. coli (EPEC) transfers its receptor for intimate adherence into mammalian cells. Cell 91:511–520CrossRefGoogle Scholar
  29. Krogfelt KA (1991) Bacterial adhesion genetics, biogenesis, and its role in pathogenesis of afrimbrial adhesins of Escherichia coli. Rev Infect Dis 13:721–735Google Scholar
  30. Kortepeter MG, Parker GW (1999) Potential biological weapons threats. Emerg Infect Dis 5(4):523–527Google Scholar
  31. Labadie J, Desnier I (1992) Selection of cell wall antigens for the rapid detection of bacteria by immunological methods. J Appl Bacteriol 72(3):220–226Google Scholar
  32. Litwin CM, Calderwood SB (1993) Role of iron in regulation of virulence genes. Clin Microbiol Rev 6:137–149Google Scholar
  33. Longworth DL (2001) Microbial drug resistance and the roles of the new antibiotics. Clev Clin J Med 68(6):496–504Google Scholar
  34. Mead PS, Slutsker L, Dietz V, Mccaig LF, Bresee JS, Shapiro C, Griffin PM, Tauxe RV (1999) Emerg Infect Dis 5:607–625Google Scholar
  35. Merrit EA, Hol WG (1995) AB5 toxins. Curr Opin Struc Biol 5:165–171CrossRefGoogle Scholar
  36. Meyer KF et al. (1974) Plague immunization. VI. Vaccination with fraction 1 antigen of Yersinia pestis. J Infect Dis 129(Suppl):S41–S45Google Scholar
  37. Meyer TF (1991) Evasion mechanisms of pathogenic Neisseriae. Behring Inst Mitt 88:194–199Google Scholar
  38. Mock M, Fouet A (2001) Anthrax. Ann Rev Microbiol 55:647–671CrossRefGoogle Scholar
  39. Neilands JB (1995) Siderophores: structure and function of microbial iron transport compounds. J Biol Chem 270:26723–26726Google Scholar
  40. Ponce-de-Leon S (1991) The needs of developing countries and the resources required. J Hosp Infect 18 (Suppl):376–381CrossRefGoogle Scholar
  41. Plowman R et al. (1999) The socioeconomic burden of hospital-acquired infection. London public health laboratory service and London school of hygiene and tropical medicineGoogle Scholar
  42. Rink L. Kirchner H (1996) Recent progress in the tumour necrosis-alpha field. Int Arch Allergy Immunol 111:199–209CrossRefGoogle Scholar
  43. Radstrom P, Knutsson R, Wollffs P, Lovenklev M, Lofstrom C (2004) Pre-PCR processing strategies to generate PCR-compatibile samples. Mol Biotechnol 26(2):133–146CrossRefGoogle Scholar
  44. Rosenshine I, Finlay BB (1993) Exploitation of host signal transduction pathways and cytoskeletal functions by invasive bacteria. Bioessays 15:17–24CrossRefGoogle Scholar
  45. Savarino SJ, Fasano A, Watson J, Martin BM, Levine MM, Guandalini S, Guerry P (1993) Enteroaggregative Escherichia coli heat stable enterotoxin 1 represents another subfamily of E coli heat stable toxin. P Natl Acad Sci USA 90:3093–3097CrossRefGoogle Scholar
  46. Schiavo G, Benfenati F, Poulain B, Rosetto O, Polverino De Laureto P, Dasgupta BR, Montecucco C (1992) Tetanus and Botulinum-B neurotoxin block neurotransmitter release by proteolytic cleavage of synaptobrevin. Nature 359:832–835Google Scholar
  47. Schmitt CK, Meysick KC, O’Brien AD (1999) Bacterial toxins: friends or foes.Emerg Infect Dis 5(2):224–234Google Scholar
  48. Smith H (1977) Microbial surfaces in relation to pathogenicity. Bacteriol Rev 41:475–500Google Scholar
  49. Soto GE, Hultgren SJ (1999) Bacterial adhesins: common themes and variation in architecture and assembly. J Bacteriol 181(4):1059–1071Google Scholar
  50. Stebbins CE, Galan JE (2001) Structural mimicry in bacterial virulence. Nature 412:701–705CrossRefGoogle Scholar
  51. Taylor CM, Roberts IS (2005) Capsular Polysaccharides and their Role in Virulence. In Russell W, Herwald H (Eds). Concepts in Bacterial virulence. Contrib Microbiol Basel, Karger, pp 55–66Google Scholar
  52. Tracey K, Cerami A (1994) Tumor necrosis factor: a pleiotrophic cytokine and therapeautic agent. Ann Rev Med 45:491–503CrossRefGoogle Scholar
  53. Tuomanen E, Weiss A (1985) Characterisation of two adhesins of Bordatella pertussis for human ciliated respiratory-epithelial cells. J Infect Dis 152:1028–125Google Scholar
  54. Turnbull PCB (1991) Anthrax vaccines: past, present, and future. Vaccine 9:533–539CrossRefGoogle Scholar
  55. US Food and Drug Administration Center for Food Safety and Applied Nutrition. Foodborne pathogenic microorganisms and natural toxins handbook. http://www.cfsan.fda.gov, June 14, 2007Google Scholar
  56. Van der Velde AWM, Bäumer AJ, Tsolis RM, Heffron F (1998) multiple fimbrial adhesins are required for full virulence of Salmonella typhimurium in mice. Infect Immun 66(6):2803–2808Google Scholar
  57. Walker T (1998) Microbiology. WB Saunders, PhiladelphiaGoogle Scholar
  58. Watson DW, Brandly CA (1949) Virulence and pathogenicity. In: Clifton CE, Raffel S, Baker HA (Eds) Annual review of microbiology. Annual Reviews Inc, Stanford CA, pp 195–220Google Scholar
  59. Webb GF (2003) A silent bomb: the risk of anthrax as a weapon of mass destruction. P Natl Acad Sci USA 100(7):4346–4351CrossRefGoogle Scholar
  60. Welch RA (1991) Pore-forming cytolysins of Gram-negative bacteria. Mol Microbiol 5:521–528CrossRefGoogle Scholar
  61. Wizemann TM, Adamou JE, Langermann S (1999) Adhesins as targets for vaccine development. Emerg Infect Dis 5(3):395–403Google Scholar
  62. Wood WB, Davis BD (1980) Host-parasite relations in bacterial infections. In: Davies BD, Dulbecco R, Eisen HN, Ginsberg HS (Eds) Microbiology. Cambridge. pp 551–571Google Scholar
  63. Wenzel RP (1995) The economics of nosocomial infections. J Hosp Infect 31:79–87CrossRefGoogle Scholar
  64. Wakefield DS et al (1988) Cost of nosocomial infection: relative contributions of laboratory antibiotic, and per diem cost in serious Staphylococcus aureus infections. Am J Infect Control 16:185–19211CrossRefGoogle Scholar
  65. World Health Organisation (2002) Prevention of hospital-acquired infections, 2nd edition. WHO/CDS/EPH/2002/12. Available from http:///www.who.int/csr/resources/publications/drugresist/WHO_CDS_CSR_EPH_2002_12/enGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Tracey Elizabeth Love
    • 1
  • Barbara Jones
    • 2
  1. 1.Defence Science and Technology LaboratoryPorton DownUK
  2. 2.Chemical Sciences and Technology Laboratory, Biochemical Science DivisionNational Institute of Standards and TechnologyGaithersburgUSA

Personalised recommendations